InvestorsHub Logo
Followers 33
Posts 2647
Boards Moderated 0
Alias Born 09/18/2006

Re: pennytiger post# 201900

Monday, 10/21/2019 11:07:33 AM

Monday, October 21, 2019 11:07:33 AM

Post# of 330543
Pretty good level of common sense. Assume very little about future deals before or after FDA responses to submissions by BIEL.

What we may consider assuming is that the market does not expect Kelly Whelan to maintain a zero profile going forward and expects her to self-nominate as co-CEO or Chair of the Board of Directors or other lofty positions she is unqualified for. Markets, investors like competence and confidence that management has the talent and experience to run things responsibly, honestly and profitably for shareholders.

What the Whelans have done for 12 years or more is use the same small amount of capital over and over and over again, to amass over 25 billion shares - over 60% of the company. Again, no large amount or new money. Shareholders have financed BIEL and have received no pps upside for years.

If the markets already had confidence the Whelan family is only going to be shareholders and nothing else, the stock price would reflect that. Remaining at .0007 tells me the market expects Kelly Whelan will foolishly name herself to one or more positions, repeating a disastrous 10 year situation for shareholders. If she doesn't and follows wise advice she has received to stay in the dark, all shareholders might do very well.

Never buy/sell a stock on my recommendation alone. Always do your own DD and be aware of the risks!